NFKB1 and adult T-cell leukemia/lymphoma: CYLD anomalies are also detected in adult T-cell leukemia/lymphoma (ATLL) cells, as hyper-phosphorylated CYLD losses its function of removing the ubiquitin chains on RIP1, leading to continuous activation of the NF-κB pathway [215].